These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19788361)

  • 1. Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest.
    Valiquette L; Low DE; McGeer AJ
    Clin Infect Dis; 2009 Nov; 49(9):1377-9. PubMed ID: 19788361
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.
    Shah SS; Hall M; Srivastava R; Subramony A; Levin JE
    Clin Infect Dis; 2009 Nov; 49(9):1369-76. PubMed ID: 19788359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Streptococcal toxic shock syndrome or Kawasaki disease? Two case studies of children with group A streptococcal pneumonia empyema].
    Bosland A; Arlaud K; Rousset-Rouvière C; Fouilloux V; Paut O; Dubus JC; Bosdure E
    Arch Pediatr; 2011 Dec; 18(12):1310-4. PubMed ID: 22041597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome.
    Schrage B; Duan G; Yang LP; Fraser JD; Proft T
    Clin Infect Dis; 2006 Sep; 43(6):743-6. PubMed ID: 16912949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on: Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
    Rajagopalan G; Patel R; Kaveri SV; David CS
    J Antimicrob Chemother; 2007 Jan; 59(1):157-9; author reply 159-60. PubMed ID: 17071954
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.
    Kaul R; McGeer A; Norrby-Teglund A; Kotb M; Schwartz B; O'Rourke K; Talbot J; Low DE
    Clin Infect Dis; 1999 Apr; 28(4):800-7. PubMed ID: 10825042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic considerations for children with invasive group a streptococcal infections: a case series report and review of the literature.
    Burnett AM; Domachowske JB
    Clin Pediatr (Phila); 2007 Jul; 46(6):550-5. PubMed ID: 17579110
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of IVIG in treatment of generalized infections].
    Lewandowicz-Uszyńska A
    Postepy Hig Med Dosw; 2002; 56 Suppl():85-90. PubMed ID: 12661418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Puerperal streptococcal toxic shock syndrome treated with recombinant human activated protein C and intravenous immunoglobulin.
    Al-Rawi S; Woodward LJ; Knight J
    Int J Obstet Anesth; 2009 Apr; 18(2):169-72. PubMed ID: 19195874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
    Sriskandan S; Ferguson M; Elliot V; Faulkner L; Cohen J
    J Antimicrob Chemother; 2006 Jul; 58(1):117-24. PubMed ID: 16670109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
    Baxter M; Morgan M
    Emerg Infect Dis; 2017 Jan; 23(1):127-129. PubMed ID: 27983491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
    Perez CM; Kubak BM; Cryer HG; Salehmugodam S; Vespa P; Farmer D
    Am J Med; 1997 Jan; 102(1):111-3. PubMed ID: 9209207
    [No Abstract]   [Full Text] [Related]  

  • 13. A survey of physician's attitudes regarding management of severe group A streptococcal infections.
    Valiquette L; Low DE; Chow R; McGeer AJ
    Scand J Infect Dis; 2006; 38(11-12):977-82. PubMed ID: 17148064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.
    Parks T; Wilson C; Curtis N; Norrby-Teglund A; Sriskandan S
    Clin Infect Dis; 2018 Oct; 67(9):1434-1436. PubMed ID: 29788397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse venous thromboemboli associated with IVIg therapy in the treatment of streptococcal toxic shock syndrome: case report and review.
    Geller JL; Hackner D
    Ann Hematol; 2005 Sep; 84(9):601-4. PubMed ID: 15815906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin therapy for toxic shock syndrome.
    Barry W; Hudgins L; Donta ST; Pesanti EL
    JAMA; 1992 Jun; 267(24):3315-6. PubMed ID: 1597914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Necrotizing fasciitis of the eyelids and toxic shock syndrome due to Streptococcus pyogenes].
    Bustos B R; Soto G G; Hickmann O L; Torres B C
    Rev Chilena Infectol; 2009 Apr; 26(2):152-5. PubMed ID: 19621147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Puerperal widespread pyomyositis after group A streptococcal toxic shock syndrome.
    Feigenberg T; Sela HY; Applbaum YH; Mankuta D
    Isr Med Assoc J; 2008 Jun; 10(6):483-4. PubMed ID: 18669156
    [No Abstract]   [Full Text] [Related]  

  • 19. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
    Neugebauer EA
    Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravenous immunoglobulin therapy in non-menstrual staphylococcal toxic shock syndrome].
    Hureau M; Saint-Léger P
    Med Mal Infect; 2018 Feb; 48(1):70-72. PubMed ID: 29050863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.